Leukemia: all 5,475 studies

Page 54 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.

• Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003961Phase 2
• Donor Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003960Phase 2
• Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic LeukemiaCompletedNCT00003934Phase 3
• Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic LeukemiaCompletedNCT00003933Not applicable
• Diagnostic Study of Gene Alterations in Patients With Acute Myeloid LeukemiaCompletedNCT00003931
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic DiseaseCompletedNCT00003913Phase 2
• Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationCompletedNCT00003887Phase 2
• Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or MyelomaStatus unknownNCT00003885Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Lymphoma or LeukemiaCompletedNCT00003874Phase 1/2
• Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic LeukemiaCompletedNCT00003870Phase 2
• Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid LeukemiaCompletedNCT00003868Phase 2
• Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic LeukemiaActive, not recruitingNCT00003861
• DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid LeukemiaCompletedNCT00003840Phase 1/2
• 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaCompletedNCT00003837Not applicable
• Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00003829Phase 2
• Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic LeukemiaCompletedNCT00003808Phase 2
• Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell CountCompletedNCT00003805Phase 3
• Genetic Study of Children With Soft Tissue Sarcoma or RhabdomyosarcomaCompletedNCT00003793
• Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00003790
• Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic LeukemiaCompletedNCT00003783Phase 2
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00003764Phase 3
• Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous LeukemiaStatus unknownNCT00003758Phase 2
• Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine TherapyCompletedNCT00003757Phase 2
• Daily or Weekly Cladribine in Treating Patients With Hairy Cell LeukemiaCompletedNCT00003746Phase 3
• Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous LeukemiaCompletedNCT00003735Phase 2
• Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic LeukemiaTerminatedNCT00003729Phase 2
• Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's LymphomaStatus unknownNCT00003728Phase 3
• Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00003727Phase 2
• Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCompletedNCT00003700Phase 2
• Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic PhaseCompletedNCT00003694Phase 2
• Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous LeukemiaCompletedNCT00003693Phase 1
• Treatment for Chronic Pain in Patients With Advanced CancerCompletedNCT00003687Phase 3
• CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First RelapseCompletedNCT00003673Phase 2
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic LeukemiaCompletedNCT00003671Phase 2
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003661Phase 2
• Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell CancersCompletedNCT00003658Phase 2
• 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating AgentsCompletedNCT00003635Phase 2
• Flavopiridol in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT00003620Phase 2
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic LeukemiaCompletedNCT00003619Phase 1/2
• Combination Chemotherapy in Treating Older Patients With Acute Myeloid LeukemiaStatus unknownNCT00003602Phase 3
• Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic SyndromeCompletedNCT00003593Phase 3
• Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersCompletedNCT00003572Phase 2
• Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaTerminatedNCT00003561Phase 2
• 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaCompletedNCT00003545Phase 2
• Raltitrexed in Treating Children With Refractory Acute LeukemiaCompletedNCT00003528Phase 1
• Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1
• Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic LeukemiaStatus unknownNCT00003437Phase 3
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid LeukemiaCompletedNCT00003436Phase 3
• Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic CancerWithdrawnNCT00003435Phase 1
• Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectCompletedNCT00003425Phase 1/2
• Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerCompletedNCT00003408Phase 2
• Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CMLWithdrawnNCT00003407Phase 2
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerCompletedNCT00003406Phase 1/2
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous LeukemiaWithdrawnNCT00003405Phase 2
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00003402Phase 2
• Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003398Phase 4
• Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003396Phase 2
• Arsenic Trioxide in Treating Patients With Advanced Hematologic CancerCompletedNCT00003395Phase 1
• Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By ChemotherapyCompletedNCT00003341Phase 3
• Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous LeukemiaCompletedNCT00003340Phase 2
• Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic CancerCompletedNCT00003335Phase 2
• Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00003331Phase 1
• Aminopterin in Treating Patients With Refractory LeukemiaCompletedNCT00003305Phase 2
• Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic CancerCompletedNCT00003294Phase 1
• Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic LeukemiaCompletedNCT00003291
• UCN-01 in Treating Patients With Advanced CancerCompletedNCT00003289Phase 1
• Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00003268Phase 1
• Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous LeukemiaCompletedNCT00003255Phase 2
• Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic LeukemiaCompletedNCT00003248Phase 2
• Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic CancerCompletedNCT00003243Phase 1
• Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00003239Phase 2
• Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous LeukemiaCompletedNCT00003230Phase 1/2
• Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic LeukemiaCompletedNCT00003217Phase 1
• Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple MyelomaCompletedNCT00003196Not applicable
• Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT00003190Phase 3
• Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic LymphomaCompletedNCT00003187Phase 2/3
• Chemotherapy in Treating Children With Recurrent Acute Myeloid LeukemiaCompletedNCT00003178Phase 2
• Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaCompletedNCT00003174Phase 1
• Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous LeukemiaCompletedNCT00003148Phase 2
• Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid LeukemiaCompletedNCT00003145Phase 2
• CMA-676 in Treating Patients With Acute Myeloid Leukemia in First RelapseCompletedNCT00003131Phase 2
• High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003116Phase 2
• Interleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsCompletedNCT00003107Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Advanced CancerCompletedNCT00003082Phase 1
• Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or LymphomaCompletedNCT00003079Phase 1
• Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid TumorsStatus unknownNCT00003073Phase 1
• Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell TransplantationTerminatedNCT00003056Phase 3
• Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous LeukemiaCompletedNCT00003005Phase 1
• Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous LeukemiaCompletedNCT00003003Phase 1
• Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeStatus unknownNCT00002989Phase 3
• Decitabine in Treating Patients With Melanoma or Other Advanced CancerCompletedNCT00002980Phase 1
• 506U78 in Treating Patients With Refractory Hematologic CancerCompletedNCT00002970Phase 2
• Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic LeukemiaTerminatedNCT00002961Phase 3
• High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00002945Phase 3
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous LeukemiaStatus unknownNCT00002926Phase 3
• Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous LeukemiaCompletedNCT00002925Phase 1/2
• Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute LeukemiaCompletedNCT00002912Phase 1
• Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00002908Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous LeukemiaCompletedNCT00002890Phase 1
• Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous LeukemiaStatus unknownNCT00002869Phase 3

← Leukemia overview